Text Size

Integrated Care for Cancer Patients; Developing, Implementing and Testing a Programme to Improve Integrated Care

The recruitment status of this study is unknown because the information has not been verified recently.
Verified February 2007 by Radboud University.
Recruitment status was  Recruiting
Sponsor:
Information provided by:
Radboud University
ClinicalTrials.gov Identifier:
NCT00135980
First received: August 25, 2005
Last updated: February 28, 2007
Last verified: February 2007
History of Changes
  Purpose

The purpose of this study is to compose, implement and evaluate a programme to improve the quality of integrated care for patients with cancer.

Literature will be searched for components of integrated care programmes. On the basis of evidence based multi-disciplinary guidelines and literature on integrated care programmes, a set of indicators will be composed. This set will be measured in 6 hospitals on patients with non-small-cell-lung cancer. In two hospitals, an integrated care programme will be implemented and effects on processes and outcomes of care will be measured.


Condition Intervention
Neoplasms
 Behavioral: professional audit and feedback
Behavioral: integrated care programmes

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Educational/Counseling/Training
Official Title: Integrated Care for Cancer Patients

Resource links provided by NLM:

MedlinePlus related topics: Cancer
U.S. FDA Resources

Further study details as provided by Radboud University:

Primary Outcome Measures:
  • guideline adherence

Secondary Outcome Measures:
  • hospitalization
  • satisfaction
  • quality of life

Estimated Enrollment: 300
Study Start Date: August 2004
Estimated Study Completion Date: July 2007
  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Each new patient that visits the lung specialist in 6 hospitals in the east part of Holland, in the period from September 2004 till March 2005

Exclusion Criteria:

  • Mortality
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00135980

Contacts
Contact: Marielle Ouwens, MSc +31243613114 M.Ouwens@kwazo.umcn.nl
Contact: Rosella Hermens, MSc,PhD +31243613129 R.Hermens@kwazo.umcn.nl

Locations
Netherlands
Rijnstate Hospital Recruiting
Arnhem, Netherlands
Contact: Hans Smit, MD         hsmit@alysis.nl    
Principal Investigator: Marielle Ouwens, MSc            
MaasHospital Pantein Recruiting
Boxmeer, Netherlands
Contact: René Bunnik, MD         mbunnik@maasziekenhuispantein.nl    
Principal Investigator: Marielle Ouwens, MsC            
Slingeland Hosptital Recruiting
Doetinchem, Netherlands
Contact: Gerrit Bosman, MD         G.Bosman@slingeland.nl    
Principal Investigator: Marielle Ouwens, MSc            
Gelderse Vallei Hospital Recruiting
Ede, Netherlands
Contact: Marietje Oudijk, MD         oudijkm@zgv.nl    
Principal Investigator: Marielle Ouwens, MSc            
Radboud University Medical Centre Recruiting
Nijmegen, Netherlands
Contact: Miep vanderDrift, MD         M.vanderdrift@ULC.umcn.nl    
Principal Investigator: Marielle Ouwens, MSc            
CWZ Hospital Recruiting
Nijmegen, Netherlands
Contact: René Termeer, MD         A.Termeer@cwz.nl    
Principal Investigator: Marielle Ouwens, MSc            
Sponsors and Collaborators
Radboud University
Investigators
Principal Investigator: Rosella Hermens, MSc,PhD Centre for Quality of Care Research, Radboud University Nijmegen Medical Centre
Study Director: Hub Wollersheim, MD,PhD Centre for Quality of Care Research, Radboud University Medical Centre
  More Information

Additional Information:
Site of the Centre for Quality of Care Research  This link exits the ClinicalTrials.gov site

Publications:

ClinicalTrials.gov Identifier: NCT00135980     History of Changes
Other Study ID Numbers: PACT-study M2100, M2100
Study First Received: August 25, 2005
Last Updated: February 28, 2007
Health Authority: Netherlands: The Central Committee on Research Involving Human Subjects (CCMO)

Additional relevant MeSH terms:
Neoplasms

ClinicalTrials.gov processed this record on May 23, 2013